Advertisement Perrigo wins approval for OTC Cetirizine Oral Solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Perrigo wins approval for OTC Cetirizine Oral Solution

Perrigo has received final approval from the FDA to manufacture and market over-the-counter children's Cetirizine Hydrochloride Oral Solution for allergy and Cetirizine Hydrochloride Oral Solution for hives-relief, 1mg/mL.

The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare’s children’s Zyrtec Oral Solution, 1mg/mL, indicated for indoor and outdoor allergy and hives relief. The company expects to begin shipping the product immediately.

Joseph Papa, Perrigo’s chairman and CEO, said: “This approval reflects our strategy to be first to market with the important products that make quality healthcare more affordable for our customers.”